MarketPeel
Insider Trading Intelligence
PM

Peter Mcnamara

TECX
CHIEF SCIENTIFIC OFFICER · TECTONIC THERAPEUTIC, INC. · CIK 0002023255
FILING MIX · LIFETIME59%/41%
BUYS
16
SELLS
11
TOTAL VALUE
$354.0K
COMPANIES
1
ACTIVE SINCE
Jun 2024
HOLDINGS NOW
55,285
AVG SELL PX
$27.28
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Peter Mcnamara, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+12.22%-1.19%+13.41%+11.29%
14d4+50.00%+3.23%-2.99%+6.21%+3.80%
30d4+50.00%+0.90%-2.97%+3.87%+0.60%
60d4+50.00%-2.26%+6.50%-8.76%-11.21%
90d4+50.00%-1.40%
180d4(4 pending)
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TECX · 55,285 shares · as of Jun 30, 2026
019,25038,50057,75077,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 11 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TECX
TECTONIC THERAPEUTIC, INC.
SALE10b5-1
10b5-1 plan
172$35.00$6.0K55,285Jun 30, 2026Jul 1, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Scientific Officer
172$14.71$2.5K55,457Jun 30, 2026Jul 1, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
1727,873Jun 30, 2026Jul 1, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE10b5-1
10b5-1 plan
6,047$30.00$181.4K55,500Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Scientific Officer
215$14.71$3.2K61,547Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Scientific Officer
2,500$2.38$6.0K61,332Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE10b5-1
10b5-1 plan
215$35.00$7.5K55,285Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
2158,045Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
2,50031,959Mar 6, 2026Mar 9, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
21,00021,000Mar 4, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
23,00060,482Mar 4, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE10b5-1
10b5-1 plan
1,650$25.00$41.3K58,832Mar 4, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE10b5-1
10b5-1 plan
1,649$22.06$36.4K37,482Mar 3, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
1,748$23.22$40.6K39,131Feb 4, 2026Feb 10, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
7,00025,065Dec 22, 2025Dec 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Scientific Officer
7,000$2.98$20.9K40,879Dec 22, 2025Dec 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
4,55033,879Sep 25, 2025Sep 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
8,2608,260Sep 25, 2025Sep 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
27,53027,530Feb 4, 2025Feb 6, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
15,14129,329Feb 4, 2025Feb 6, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Scientific Officer
3,500$2.38$8.3K14,188Dec 3, 2024Dec 5, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Scientific Officer
3,50034,459Dec 3, 2024Dec 5, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
18,70418,704Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
10,68810,688Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
37,95937,959Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
77,00077,000Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
32,06532,065Jun 20, 2024Jun 24, 2024View →
Other insiders · TECX
Loading peer insiders…
About this filer
CIK 0002023255
ROLE
Chief Scientific Officer
PRIMARY
TECX
COMPANIES
1
ACTIVE SINCE
Jun 2024
MARKETPEEL · /INSIDER/0002023255DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback